skip to content

Finkelstein, Stan N.

Overview
Works: 26 works in 37 publications in 2 languages and 1,109 library holdings
Genres: Conference proceedings 
Classifications: HD9666.4, 338.4361510973
Publication Timeline
Key
Publications about Stan N Finkelstein
Publications by Stan N Finkelstein
Most widely held works by Stan N Finkelstein
Reasonable Rx : solving the drug price crisis by Stan N Finkelstein( Book )
6 editions published in 2008 in English and held by 763 libraries worldwide
Explores the problem of high drug prices by taking a close look at the science of drug development, how the drug industry operates, how new drugs are discovered, and how the government affects and controls these processes. By examining recent changes in the pharmaceutical industry in more depth, the authors explain how more radical changes can both reduce prices and improve the flow of new drugs
The American blood supply by Alvin W Drake( Book )
2 editions published in 1982 in English and held by 298 libraries worldwide
Reasonable Rx : how to lower drug prices by Stan N Finkelstein( Book )
1 edition published in 2008 in English and held by 6 libraries worldwide
Reasonable Rx : solving the drug pricing crisis by Stan N Finkelstein( Book )
1 edition published in 2008 in English and held by 6 libraries worldwide
Benefit plan design and prescription drug utilization among asthmatics : do patient copayments matter? by William H Crown( Book )
4 editions published in 2003 in English and held by 6 libraries worldwide
Objective: The ratio of controller to reliever medication use has been proposed as a measure of treatment quality for asthma patients. In this study we examine the effects of plan level mean out-of-pocket asthma medication patient copayments and other features of benefit plan design on the use of controller medications alone, controller and reliever medications (combination therapy), and reliever medications alone. Methods: 1995-2000 MarketScan claims data were used to construct plan-level out-of-pocket copayment and physician/practice prescriber preference variables for asthma medications. Separate multinomial logit models were estimated for patients in fee-for-service (FFS) and non-FFS plans relating benefit plan design features, physician/practice prescribing preferences, patient demographics, patient comorbidities and county-level income variables to patient-level asthma treatment patterns. Results: We find that the controller reliever ratio rose steadily over 1995-2000, along with out-of-pocket payments for asthma medications, which rose more for controllers than for relievers. However, after controlling for other variables, plan level mean out-of-pocket copayments were not found to have a statistically significant influence upon patient-level asthma treatment patterns. On the other hand, physician practice prescribing patterns strongly influenced patient level treatment patterns. Conclusions: There is no strong statistical evidence that higher levels of out-of-pocket copayments for prescription drugs influence asthma treatment patterns. However, physician/practice prescribing preferences influence patient treatment
Biomedical innovation : the challenge and the process by Stan N Finkelstein( Book )
1 edition published in 1981 in English and held by 3 libraries worldwide
Modeling the development and dissemination of an emerging medical technology ( Book )
1 edition published in 1981 in English and held by 3 libraries worldwide
A two-stage model for the control of epidemic influenza by Stan N Finkelstein( Book )
1 edition published in 1980 in English and held by 2 libraries worldwide
Product designs which encourage -- or discourage -- related innovation by users : an analysis of innovation in automated clinical chemistry analyzers by Eric von Hippel( Book )
2 editions published in 1978 in English and held by 2 libraries worldwide
Medical cost savings from Pentoxifylline therapy in chronic occlusive arterial disease by Kevin Neels( Book )
2 editions published in 1997 in English and held by 2 libraries worldwide
Vpliv izsledkov kliničnih študij na trend predpisovanja zaviralcev alfa-adrenergičnih receptorjev, 1996-2002 = (Impact of clinical trial results on national trends in alpha-blocker prescribing, 1996-2002) ( Article )
1 edition published in 2004 in Slovenian and held by 2 libraries worldwide
Izhodišče: Proučevanje dejavnikov, ki vplivajo na vzorce predpisovanja zdravil, in njihovo spreminjanje na podlagi izsledkov kliničnih raziskav je omejeno. Cilj: Proučitev sprememb pri predpisovanju zaviralcev alfa-adrenergičnih receptorjev za zdravljenje hipertenzije pred aprilom 2000, ko je bil zaradi neugodnih izsledkov objavljen zgodnji konec raziskave antihipertenzivnega zdravljenja in zniževanja lipidov za preprečevanje srčnih dogodkov (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial - ALLHAT). Raziskava se je nanašala na uporabo doksazosin mezilata. Spremembe v predpisovanju smo tehtali upoštevaje druge možne vzporedne vplive na uporabo zdravil med letoma 1996 in 2002, vključno s spremembami cen zaviralcev alfa-adrenergičnih receptorjev, prehodom na generična zdravila, promocijo zdravil in tekmovanje na tržišču. Zasnova, kraj raziskave in bolniki: Na podlagi dveh poročil o ameriških farmacevtskih tržnihraziskavah, ki ju je objavil IMS HEALTH, smo sledili predpisovanje zaviralcev alfa-adrenergičnih receptorjev, objavljeno v National Prescription Audit - v naključnem računalniškem vzorcu so zajeli okoli 20.000 izmed 29.000 javnih samostojnih lekarn in lekarn za naročanje po pošti ter veledrogerij in diskontnih hiš - ter vzorec predpisovanja zaviralcev alfa-adrenergičnih receptorjev v zdravniških ordinacijah, objavljen v National Disease and Therapeutic Index - v katerem so zajeli naključni stratificirani vzorec okoli 3.500 zdravniških ordinacij. Kazalci izida: Trendi uporabe zaviralcev alfa-adrenergičnih receptorjev po poročilih zdravnikov in predpisovanje ter izdajanje zaviralcev alfa-adrenergičnih receptorjev v lekarnah Združenih držav. Rezultati: V času od 1996 do konca 1999 sta nenehno naraščali število na novo predpisanih zaviralcev alfa-adrenergičnih receptorjev in izdanih zdravil v lekarnah ter zdravniška uporaba zdravil. (Izvleček skrajšan pri 2000znakih)
Projecting the impact of the 1976 medical device amendments on innovation in clinical chemistry tests by Stan N Finkelstein( Book )
1 edition published in 1980 in English and held by 2 libraries worldwide
Vaccine availability in the United States during the 2009 H1N1 outbreak by Stan N Finkelstein( Article )
1 edition published in 2011 in English and held by 1 library worldwide
An approach to studying the cost-behavior of changing utilization of a hospital laboratory by Stan N Finkelstein( Book )
1 edition published in 1980 in English and held by 1 library worldwide
Lost work productivity and absenteeism among parents of children with asthma ( Book )
1 edition published in 2000 in English and held by 1 library worldwide
Modeling the development and dissemination of an emerging medical technology ( Book )
1 edition published in 1981 in English and held by 1 library worldwide
Economics of pharmaceuticals : a global perspective ( Book )
1 edition published in 1993 in English and held by 1 library worldwide
Scientific evidence and the abandonment of medical technology : a study of eight drugs by Stan N Finkelstein( Book )
1 edition published in 1983 in English and held by 1 library worldwide
Studies in bonding heparin to silicone rubber by Stan N Finkelstein( Book )
1 edition published in 1971 in English and held by 1 library worldwide
Economies of scale in the pharmaceutical industry by Peter Temin( Book )
1 edition published in 1996 in English and held by 1 library worldwide
 
moreShow More Titles
fewerShow Fewer Titles
Alternative Names
Finkelstein, Stan
Finkelstein Stan N.
Languages
English (30)
Slovenian (1)
Covers
Close Window

Please sign in to WorldCat 

Don't have an account? You can easily create a free account.